featured
Nomograms for Predicting Survival in Patients With De Novo Metastatic TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Scientific Reports
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer
Sci Rep 2022 Aug 29;12(1)14659, MS Chen, PC Liu, JZ Yi, L Xu, T He, H Wu, JQ Yang, Q LvFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.